Citas bibligráficas
Moreno, S., (2016). Hemoglobina glicosilada como predictor de morbimortalidad en pacientes no diabéticos politraumatizados del hospital regional docente de Trujillo [Tesis, Universidad Privada Antenor Orrego]. https://hdl.handle.net/20.500.12759/2126
Moreno, S., Hemoglobina glicosilada como predictor de morbimortalidad en pacientes no diabéticos politraumatizados del hospital regional docente de Trujillo [Tesis]. PE: Universidad Privada Antenor Orrego; 2016. https://hdl.handle.net/20.500.12759/2126
@misc{renati/1349681,
title = "Hemoglobina glicosilada como predictor de morbimortalidad en pacientes no diabéticos politraumatizados del hospital regional docente de Trujillo",
author = "Moreno Arevalo, Sergio Francisco",
publisher = "Universidad Privada Antenor Orrego",
year = "2016"
}
To determine if the glycosylated hemoglobin is a predictor of morbimortality in the patient does not diabetic polytraumatized the Hospital Regional Docente de Trujillo of 15 January to 15 February 2016. Material and Method: Design Studio analytical, prospective study of diagnostic tests; in 59 non-diabetic patients with multiple trauma attended in the emergency service of the Hospital Regional Docente de Trujillo between 15 January to 15 February 2016. The 59 patients who met the inclusion criteria and after obtaining informed consent on the part of their families, they proceeded to carry out the removal of blood sample for the dosages of your HbA 1 c. They were later conducted a follow-up during their hospital stay, with a maximum period of 15 days; during this period is recorded if developed or not morbidities, death and/or a favorable evolution. It was calculated the sensibility, specificity, positive predictive value, negative and averages of glycosylated hemoglobin. Applied the Student t test and Fisher exact test. Results: The values of sensitivity, specificity, and positive and negative predictive value of the glycosylated hemoglobin as a predictor of morbidity in non-diabetic patients with multiple trauma of the Hospital Regional Docente de Trujillo of 15 January to 15 February 2016 were 77.78%, 86.96%, 90.32% and 71.43% respectively. The presence of morbidity was significantly higher in the group with HbA 1 c high wi 28 (77.78%) patients, with regard to those who had a normal HbA1 c with 3 (13.04%) patients (p=0.000). Conclusion: The glycosylated hemoglobin is a predictor of morbidity in the patient non-diabetic polytraumatized the Hospital Regional Docente de Trujillo of 15 January to 15 February 2016, however is not predictor of mortality.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons